Overview
Gerald Gehr is an Oncologist in Manchester, New Hampshire. Dr. Gehr is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor Predisposition Syndrome. His top areas of expertise are Thrombocytopenia, Angiosarcoma, Paget Disease of the Breast, and Cutaneous T-Cell Lymphoma (CTCL).
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Katherine Thornton is an Oncologist in Boston, Massachusetts. Dr. Thornton is rated as an Elite provider by MediFind in the treatment of Rhabdoid Tumor Predisposition Syndrome. Her top areas of expertise are Adult Soft Tissue Sarcoma, Angiosarcoma, Synovial Sarcoma, and Bone Tumor.
Dana-Farber Cancer Institute, Inc.
Priscilla Merriam is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Merriam is rated as an Elite provider by MediFind in the treatment of Rhabdoid Tumor Predisposition Syndrome. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Alveolar Soft Part Sarcoma, and Epithelioid Sarcoma. Dr. Merriam is currently accepting new patients.
Jeffrey Morgan is an Oncologist in Boston, Massachusetts. Dr. Morgan is rated as a Distinguished provider by MediFind in the treatment of Rhabdoid Tumor Predisposition Syndrome. His top areas of expertise are Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, Gastrointestinal Stromal Tumor, and Bone Tumor.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ThrombocytopeniaDr. Gehr isDistinguished. Learn about Thrombocytopenia.
- Advanced
- AngiosarcomaDr. Gehr isAdvanced. Learn about Angiosarcoma.
- Cutaneous T-Cell Lymphoma (CTCL)
- Paget Disease of the BreastDr. Gehr isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Gehr isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Soft Tissue SarcomaDr. Gehr isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Gehr isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Alveolar Soft Part SarcomaDr. Gehr isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Arteriovenous MalformationDr. Gehr isExperienced. Learn about Arteriovenous Malformation.